Addentax (ATXG) had the highest return in August 2022 by a US stock in the Nasdaq Composite (IXIC), returning 2,331.6%.

ASSET	MONTH	% RETURN
Addentax (ATXG)	August 2022	2,331.63%
Applied DNA Sciences (APDN)	August 2022	352.17%
Minerva Neurosciences (NERV)	August 2022	316.24%
Reviva Pharmaceuticals (RVPH)	August 2022	313.21%
FlexShopper (FPAY)	August 2022	192.22%
Nuwellis (NUWE)	August 2022	159.48%
Bioatla (BCAB)	August 2022	158.46%
RDE (GIFT)	August 2022	147.62%
Neuroone Medical Technologies (NMTC)	August 2022	112.5%
Alaunos Therapeutics (TCRT)	August 2022	112.07%
TDH (PETZ)	August 2022	111.5%
Astria Therapeutics (ATXS)	August 2022	110.54%
AN2 Therapeutics (ANTX)	August 2022	105.02%
Bright Minds Biosciences (DRUG)	August 2022	97.94%
Locafy (LCFY)	August 2022	95.41%
Mink Therapeutics (INKT)	August 2022	94.66%
TuanChe ADR (TC)	August 2022	84.75%
Altimmune (ALT)	August 2022	83.85%
Verona Pharma PLC ADR (VRNA)	August 2022	83.77%
Rhythm Pharmaceuticals (RYTM)	August 2022	81.53%
Terns Pharmaceuticals (TERN)	August 2022	78.08%
Direct Digital (DRCT)	August 2022	76.16%
374Water Inc Common Stock (SCWO)	August 2022	75.56%
Regis Corporation Common Stock (RGS)	August 2022	75.44%
Aquestive Therapeutics (AQST)	August 2022	72.02%